Health Ministry issues advisory on use of Remdesivir for COVID treatment; here's what latest evidence suggests
A peer reviewed study titled Early Remdesivir to Prevent Progression to Severe Covid 19 in Outpatients found that patients who received a 3 day course of Remdesivir had an 87 per cent lower risk of Covid 19 related death
Source: jagran.com